Pitolisant Oral Tablet
HBS-101-CL-005
Phase 2 small_molecule completed
Quick answer
Pitolisant Oral Tablet for Myotonic Dystrophy 1 is a Phase 2 program (small_molecule) at Harmony Biosciences Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Harmony Biosciences Holdings
- Indication
- Myotonic Dystrophy 1
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed